Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Neutropenia and agranulocytosis

Haematology and transfusion · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Fever, rigors, hypotension, confusion, breathlessness, severe mouth ulceration or perianal pain with severe neutropenia requires immediate neutropenic-sepsis assessment and empirical antibiotics. Do not wait for repeat counts or obvious pus. Stop a suspected high-risk culprit such as carbimazole or clozapine under its emergency monitoring pathway, while ensuring abrupt withdrawal of an essential medicine does not create a separate unmanaged crisis.

Synopsis

Grade neutrophil deficiency, recognise infection despite muted signs, identify drug, immune, nutritional, infective and marrow causes, and stop culpable exposure while supporting safe recovery.

  • Neutropenia is a reduced absolute neutrophil count, commonly graded as mild 1.0–1.5, moderate 0.5–1.0 and severe below 0.5 × 10^9/L, with context and duration determining risk.
  • Agranulocytosis usually denotes profound neutropenia, often drug induced, with a high risk of rapidly progressive bacterial or fungal infection.
  • Repeat an unexpected result and inspect the film, but treat fever or physiological instability immediately rather than waiting to prove persistence.
  • Medicine reconciliation must include recent courses and stopped drugs: antithyroid medicines, clozapine, metamizole exposure abroad, sulfasalazine, antiepileptics, antimicrobials and cytotoxic or immune therapies.
  • Viral infection can transiently lower neutrophils, while HIV, hepatitis, EBV or CMV may produce a prolonged pattern guided by exposure and symptoms.
  • B12, folate and copper deficiency can suppress several lines; isolated neutropenia with normal indices makes a global nutritional cause less likely but not impossible.
  • Duffy-null-associated neutrophil counts are a healthy inherited reference variant common in some ancestries and should not be labelled disease after appropriate assessment.
  • Lymphadenopathy, splenomegaly, blasts, dysplasia, other cytopenias or progressive constitutional symptoms raise marrow malignancy, autoimmune disease or hypersplenism.
  • Bone-marrow examination is used for unexplained persistent, severe or multilineage cytopenia, not automatically for every stable mild count.
  • Granulocyte colony-stimulating factor is used for defined chemotherapy, congenital or severe drug-related settings under specialist guidance and does not replace antibiotics in sepsis.

Key red flags

Septic physiology

Hypotension, confusion, raised lactate or hypoxia with neutropenia needs immediate antibiotics and organ support regardless of temperature.

Investigation priorities

01
Repeat full count and manual filmFirst step

Confirm severity and detect other lineage or morphological clues.

Management branches

Safety screenSeparate fever from a stable number

A low neutrophil count is newly reported or found during illness.

  1. Assess temperature, haemodynamics, mucosa, skin, lines, respiratory and perianal symptoms immediately and treat septic physiology through the acute pathway.
  2. Repeat count and film, retrieve prior values and grade depth and duration while taking cultures and giving antibiotics when fever or instability is present.
  3. Apply medicine-specific emergency rules, withholding a plausible culprit and coordinating essential-disease replacement with the responsible specialist.

Key medicines

FilgrastimHaematology or oncology uses a weight-based subcutaneous regimen for a defined chemotherapy, congenital or severe drug-related indication, adjusting duration to neutrophil recovery and clinical context.Bone pain, splenic enlargement or rupture, leucocytosis, lung injury and sickle crisis are recognised; it does not replace antibiotics or source control in infection.
Culprit medicine withdrawalWithhold further doses immediately under the product-specific agranulocytosis pathway and do not rechallenge unless a national monitoring service and senior specialist explicitly authorise it.Coordinate clozapine, antithyroid or seizure treatment alternatives urgently; document the reaction and avoid inadvertent exposure to the same or cross-reactive agent.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE neutropenic sepsis recommendationsImmediate recognition, empirical antibiotics and acute risk assessment.
  • BNF carbimazole monographAgranulocytosis symptoms, medicine cessation and urgent count advice.
  • MHRA clozapine blood-monitoring updateUK clozapine neutrophil monitoring and action framework.
  • NHS Genomic Medicine Duffy-null resourceConstitutional lower neutrophil counts, interpretation and equitable care.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom